Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OJ7E
|
|||
| Former ID |
DNC009011
|
|||
| Drug Name |
3'-carbamoylbiphenyl-3-yl 6-phenylhexylcarbamate
|
|||
| Synonyms |
CHEMBL451909; 887264-44-0; C26H28N2O3; JP83; MolPort-009-019-196; HMS3650I04; BDBM50275301; 1384AH; ZINC27646193; AKOS027282688; 3'-Carbamoyl-biphenyl-3-yl-hexylphenylcarbamate; SR-01000946289; 3''-carbamoylbiphenyl-3-yl 6-phenylhexylcarbamate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H28N2O3
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CCCCCCNC(=O)OC2=CC=CC(=C2)C3=CC(=CC=C3)C(=O)N
|
|||
| InChI |
1S/C26H28N2O3/c27-25(29)23-15-8-13-21(18-23)22-14-9-16-24(19-22)31-26(30)28-17-7-2-1-4-10-20-11-5-3-6-12-20/h3,5-6,8-9,11-16,18-19H,1-2,4,7,10,17H2,(H2,27,29)(H,28,30)
|
|||
| InChIKey |
JMLPLSJWSHVJLP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors. J Med Chem. 2008 Dec 11;51(23):7327-43. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.